Marvin Martens, MSc (M.T.L.J.)

Mortensen, H. M., Gromelski, M., Hench, G., Martens, M., Wittwehr, C., Kumar, S., Kumar, V., Audouze, K., Virvilis, V., Nymark, P., Angrish, M., Lynch, I., Edwards, S., Magagna, B., Wojewodzic, M. W., & The FAIR AOP Cluster Working Group (2025). The FAIR AOP roadmap for 2025: Advancing findability, accessibility, interoperability, and re-usability of adverse outcome pathways. Computational Toxicology, 35, Article 100368. https://doi.org/10.1016/j.comtox.2025.100368

Yarar, N., Martens, M., Rognes, T., Lavender, J., Dirven, H., Audouze, K., Wojewodzic, M. W., & Fraternali, F. (Ed.) (2025). AOP-networkFinder — A versatile tool for the reconstruction and visualization of adverse Outcome Pathway networks from AOP-Wiki. Bioinformatics Advances, 5(1), Article vbaf007. https://doi.org/10.1093/bioadv/vbaf007

Mortensen, H. M., Amos, J. D., Exner, T. E., Flores, K., Harper, S., Jarabek, A. M., Klaessig, F., Lobaskin, V., Lynch, I., Marcum, C. S., Martens, M., Brough, B., Spadola, Q., & Bjorkland, R. (2024). NNI nanoinformatics conference 2023: Movement toward a common infrastructure for federal nanoEHS data computational toxicology: Short communication. Computational Toxicology, 30, Article 100316. https://doi.org/10.1016/j.comtox.2024.100316

van Rijn, J. P. M., Martens, M., Ammar, A., Cimpan, M. R., Fessard, V., Hoet, P., Jeliazkova, N., Murugadoss, S., Vinkovic Vrcek, I., & Willighagen, E. L. (2024). From papers to RDF-based integration of physicochemical data and adverse outcome pathways for nanomaterials. Journal of Cheminformatics, 16(1), Article 49. https://doi.org/10.1186/s13321-024-00833-0

Nymark, P., Clerbaux, L. A., Amorim, M. J., Andronis, C., de Bernardi, F., Bezemer, G. F. G., Coecke, S., Gavins, F. N. E., Jacobson, D., Lekka, E., Margiotta-Casaluci, L., Martens, M., Mayasich, S. A., Mortensen, H. M., Kim, Y. J., Sachana, M., Tanabe, S., Virvilis, V., Edwards, S. W., & Halappanavar, S. (2024). Building an Adverse Outcome Pathway network for COVID-19. Frontiers in Systems Biology, 4, Article 1384481. https://doi.org/10.3389/fsysb.2024.1384481

Murugadoss, S., Vinkovic Vrcek, I., Schaffert, A., Paparella, M., Pem, B., Sosnowska, A., Stepnik, M., Martens, M., Willighagen, E. L., Puzyn, T., Roxana Cimpan, M., Lemaire, F., Mertens, B., Dusinska, M., Fessard, V., & Hoet, P. H. (2024). Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals. ALTEX, 41(1), 76-90. https://doi.org/10.14573/altex.2305011

Agrawal, A., Balci, H., Hanspers, K., Coort, S. L., Martens, M., Slenter, D. N., Ehrhart, F., Digles, D., Waagmeester, A., Wassink, I., Abbassi-Daloii, T., Lopes, E. N., Iyer, A., Acosta, J. M., Willighagen, L. G., Nishida, K., Riutta, A., Basaric, H., Evelo, C. T., ... Pico, A. R. (2024). WikiPathways 2024: next generation pathway database. Nucleic acids research, 52(D1), D679–D689. https://doi.org/10.1093/nar/gkad960

Wittwehr, C., Clerbaux, L.-A., Edwards, S., Angrish, M., Mortensen, H., Carusi, A., Gromelski, M., Lekka, E., Virvilis, V., Martens, M., Bonino da Silva Santos, L. O., & Nymark, P. (2024). Why adverse outcome pathways need to be FAIR. ALTEX, 40(4), 50-56. https://doi.org/10.14573/altex.2307131

Martens, M., Stierum, R., Schymanski, E. L., Evelo, C. T., Aalizadeh, R., Aladjov, H., Arturi, K., Audouze, K., Babica, P., Berka, K., Bessems, J., Blaha, L., Bolton, E. E., Cases, M., Damalas, D. ., Dave, K., Dilger, M., Exner, T., Geerke, D. P., ... Et al. (2023). ELIXIR and Toxicology: a community in development. F1000Research, 10(1), Article 1129. https://doi.org/10.12688/f1000research.74502.2